Our clinicians review your health profile and labs to determine whether GLP-1 treatment is right for you
Injection site may vary based on your knees range of motion, ability to fully extend, the presence of fluid collection in the knee, and physician discretion
possible ADA session expansion) Q4 2026: NDA submission to FDA 2027: Standard FDA review (610 months) If Lilly uses the Commissioner's National Priority Voucher the same accelerated pathway that compressed orforglipron's review to 50 days retatrutide approval could land as early as Q1 2027
PT-141 peptide therapy at Fountain of You MD is a safe, effective solution for women and men who want a fast-acting, non-hormonal approach to enhanced arousal and sexual satisfaction
As fat cells shrink, they release stored water, temporarily increasing urine output in many people
Your treatment plan will need adjustment to ensure the best outcomes for both you and your baby